Although METTL13 has been implicated to be an important oncogene in various cancers, some studies also demonstrated its tumor suppressive function in bladder cancer and clear cell renal cell carcinoma (Liu et al. 2021; Zhang et al. 2016). The gene discussed is METTL13; the disease is cancer.